| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Email: |
y.liu@mail.biobiopha.com |
| Products Intro: |
Product Name:Dehydrocrenatine
CAS:26585-13-7
Purity:98.0% Package:5mg Remarks:BBP00638
|
|
| | 1-Vinyl-4-methoxy-β-carboline Basic information |
| Product Name: | 1-Vinyl-4-methoxy-β-carboline | | Synonyms: | 1-Vinyl-4-methoxy-β-carboline;4-methoxy-1-vinyl-9H-pyrido[3,4-b]indole;1-Ethenyl-4-methoxy-9H-pyrido[3,4-b]indole;1-vinyl-4-dimethoxy-beta-carboline;9H-Pyrido[3,4-b]indole, 1-ethenyl-4-methoxy-;Dehydrocrenatine | | CAS: | 26585-13-7 | | MF: | C14H12N2O | | MW: | 224.26 | | EINECS: | | | Product Categories: | | | Mol File: | 26585-13-7.mol |  |
| | 1-Vinyl-4-methoxy-β-carboline Chemical Properties |
| | 1-Vinyl-4-methoxy-β-carboline Usage And Synthesis |
| Uses | Dehydrocrenatidine, a β-carboline alkaloid that can be isolated from Picrasma quassioides. Dehydrocrenatidine induces cell apoptosis by activates ERK and JNK. Dehydrocrenatidine inhibits invasion and migration of cancer cells, it also suppresses neuronal excitability to exert analgesic effects[1][2]. | | References | [1] Ho HY, et al. Apoptotic effects of dehydrocrenatidine via JNK and ERK pathway regulation in oral squamous cell carcinoma. Biomed Pharmacother. 2021 May;137:111362. DOI:10.1016/j.biopha.2021.111362
[2] Hsieh MC, et al. Dehydrocrenatidine extracted from Picrasma quassioidesinduces the apoptosis of nasopharyngeal carcinoma cells through the JNK and ERK signaling pathways. Oncol Rep. 2021 Aug;46(2):166. DOI:10.3892/or.2021.8117 |
| | 1-Vinyl-4-methoxy-β-carboline Preparation Products And Raw materials |
|